Thermo Fisher Scientific (NYSE: TMO) Q3 Earnings Report

Thermo Fisher Scientific reported its third-quarter earnings per share (EPS) at $5.28, exceeding the analyst estimate of $5.25 by $0.03. Revenue for the quarter was $10.6 billion, slightly below the consensus estimate of $10.63 billion.

Guidance

Thermo Fisher Scientific provided guidance for fiscal year (FY) 2024 EPS in the range of $21.35-$22.07, against an analyst consensus of $21.72. They project FY 2024 revenue between $42.40 billion and $43.30 billion, compared to the analyst consensus of $42.91 billion.

The company’s stock price closed at $586.38, experiencing a decrease of -3.42% over the last three months, but showing an increase of 27.96% over the last twelve months.

In the past 90 days, Thermo Fisher Scientific recorded 0 positive EPS revisions and 20 negative EPS revisions. You can find details on the stock price’s past reactions to earnings here.

According to InvestingPro, Thermo Fisher Scientific has a Financial Health score classified as good performance.

For more information, check out Thermo Fisher Scientific's recent earnings performance and financials on Investing.com.

Stay updated on upcoming earnings reports by visiting Investing.com's earnings calendar.